Skip to search formSkip to main contentSkip to account menu

Leukemia, Plasma Cell

Known as: Plasma Cell Leukemias, cells leukemia plasma, LEUKEMIA PLASMACYTIC 
An aggressive plasma cell neoplasm characterized by the presence of neoplastic plasma cells in the peripheral blood. It is characterized by the… 
National Institutes of Health

Related topics

Related topics

25 relations
Atypical lymphocyteB lymphoblastB-LymphocytesBone Marrow

Broader (2)

Plasma Cell Neoplasmleukemia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition
The presence of circulating plasma cells in patients with multiple myeloma is considered a marker for highly proliferative… 
Review
2013
Review
2013
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
Plasma cell leukemia (PCL) is a rare and aggressive variant of myeloma characterized by the presence of circulating plasma cells… 
Highly Cited
2012
Highly Cited
2012
Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides.
The longitudinal evolution of a myeloma genome from diagnosis to plasma cell leukemia has not previously been reported. We used… 
Review
2012
Review
2012
How I treat plasma cell leukemia.
Primary plasma cell leukemia (pPCL) is a rare and aggressive plasma cell proliferative disorder with a very poor prognosis and… 
Highly Cited
1999
Highly Cited
1999
Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics.
We report on a series of 26 patients diagnosed with primary (de novo) plasma cell (PC) leukemia (PCL) in whom we analyzed the… 
Highly Cited
1998
Highly Cited
1998
The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma
In this study, we show that malignant plasma cells from patients with either primary (n = 12) or secondary (n = 15) plasma cell… 
Highly Cited
1997
Highly Cited
1997
The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
Chromosome rearrangement of 14q32.33 has recurrently occurred with variable partner sites, including 11q13.3, 8q24.1, 18q21.3… 
Highly Cited
1989
Highly Cited
1989
Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.
Using a specific and very sensitive (1 pg = 1 U) bioassay, we investigated the presence of IL-6, a potent myeloma cell growth… 
Highly Cited
1982
Highly Cited
1982
A human‐human hybridoma system based on a fast‐growing mutant of the ARH‐77 plasma cell leukemia‐derived line
A rapidly‐growing, HAT‐sensitive cell line LICR‐LON‐HMy2 has been derived from the ARH‐77 human plasma cell leukemia‐derived line… 
Highly Cited
1947
Highly Cited
1947
DISEASE
Background: Little is known about patients who frequently visit the emergency department (ED) for acute exacerbation of chronic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)